Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Are you more likely to recommend radiation over omission? Whole breast over APBI?
Answer from: Radiation Oncologist at Community Practice
It doesn’t change the recommendation. If adequate, imaging and surgery are done, like any other DCIS.
Sign In
or
Register
to read more
28151
Related Questions
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
How do you treat dermal metastases in the setting of prior breast irradiation?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
Would you consider whole breast re-irradiation in a patient with a second/recurrent breast cancer and prior history of breast radiation therapy many years ago, if the tumor characteristics are not amenable to partial breast re-irradiation?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Would you offer partial breast irradiation for a patient who otherwise meets PBI guidelines but has a PTEN mutation?
What are your top takeaways in Breast Cancer from ESMO 2025?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?
What are your top takeaways in Radiation Oncology from SABCS 2025?